Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of a 12-week candesartan treatment
compared with hydrochlorothiazide on insulin sensitivity assessed with hyperinsulinemic
euglycemic clamp.
Phase:
Phase 2
Details
Lead Sponsor:
Umeå University
Collaborators:
AstraZeneca Sahlgrenska University Hospital, Sweden